Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Agilent, Mogene, iSpecimen, and More

NEW YORK (GenomeWeb) – Agilent Technologies announced today that its board of directors has increased the company's quarterly dividend to 13.2 cents per share of common stock. The dividend will be paid on Jan. 25 to all shareholders of record as of Jan. 3.

Mogene said this week that it plans to start using BioNano Genomics' optical genome mapping Irys System at its Bio Research & Development Growth Park facility at the Danforth Plant Science Center. Mogene said adding BioNano's technology to its suite of offerings will allow it to better create reference-quality genome assemblies for non-model organisms for which no reference exists or for organisms with existing assemblies that would benefit from improvement or diversification. 

Customized human biospecimen collections developer iSpecimen said this week that it has signed an agreement to help New Mexico-based commercial lab TriCore Reference Laboratories make patient biospecimens and associated data available for research. iSpecimen will use its cloud-based technology to analyze data generated by TriCore to match researchers with annotated, de-identified samples for their studies.

Proteomics International Laboratories said this week it will team up with Linear Clinical Research to offer a combined advanced analytical testing and clinical trial package starting in January.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.